Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00212329 · ClinicalTrials.gov registry record
T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus
A clinical trial, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- 100
- Enrollment target
NCT00212329: Completed study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
NCT00212329 is a clinical trial that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00212329 has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Type 1 diabetes is a condition that is caused in part by an abnormality of the immune system which occurs when T cells, which are part of the immune system, damage the insulin secreting cells (islet cells) in the pancreas. Although it is known that T cells are important mediators of the disease, progress in the development of reliable T cell assays has been modest. The purpose of this study is to learn which T cell assays are most reliable and reproducible so that the investigators can improve their understanding about how type 1 diabetes occurs.
Interventions
- PROCEDURE T Cell Proliferation and Autoreactivity Assays
- PROCEDURE Cellular Immunoblot Assays
- PROCEDURE Tetramer Studies
- PROCEDURE Cytokine ELISPOT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2005-09 |
| Est. Completion | 2007-09 |
What the finished NCT00212329 record still lists
NCT00212329 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 4 interventions - of which T Cell Proliferation and Autoreactivity Assays is the first listed.
NCT00212329 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00212329 about?
NCT00212329 is a clinical study titled "T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus". Type 1 diabetes is a condition that is caused in part by an abnormality of the immune system which occurs when T cells, which are part of the immune system, damage the insulin secreting cells (islet cells) in the pancreas. Although it is known that T cells are important mediators of the disease, pro...
What is the current status of trial NCT00212329?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2005-09. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00212329?
The interventions under investigation include: T Cell Proliferation and Autoreactivity Assays (PROCEDURE), Cellular Immunoblot Assays (PROCEDURE), Tetramer Studies (PROCEDURE), Cytokine ELISPOT (PROCEDURE).
Who is sponsoring clinical trial NCT00212329?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia